These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 30125365)

  • 1. The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes.
    McHugh KR; DeVore AD; Mentz RJ; Edmonston D; Green JB; Hernandez AF
    Clin Cardiol; 2018 Sep; 41(9):1259-1267. PubMed ID: 30125365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.
    Seferović PM; Petrie MC; Filippatos GS; Anker SD; Rosano G; Bauersachs J; Paulus WJ; Komajda M; Cosentino F; de Boer RA; Farmakis D; Doehner W; Lambrinou E; Lopatin Y; Piepoli MF; Theodorakis MJ; Wiggers H; Lekakis J; Mebazaa A; Mamas MA; Tschöpe C; Hoes AW; Seferović JP; Logue J; McDonagh T; Riley JP; Milinković I; Polovina M; van Veldhuisen DJ; Lainscak M; Maggioni AP; Ruschitzka F; McMurray JJV
    Eur J Heart Fail; 2018 May; 20(5):853-872. PubMed ID: 29520964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Type 2 Diabetes Mellitus and Heart Failure: Innovative Possibilities for Management of Prognosis].
    Kobalava ZD; Yeshniyazov NV; Medovchshikov VV; Khasanova ER
    Kardiologiia; 2019 Apr; 59(4):76-87. PubMed ID: 31002044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions.
    Ofstad AP; Atar D; Gullestad L; Langslet G; Johansen OE
    Heart Fail Rev; 2018 May; 23(3):303-323. PubMed ID: 29516230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus.
    Asleh R; Sheikh-Ahmad M; Briasoulis A; Kushwaha SS
    Heart Fail Rev; 2018 May; 23(3):445-459. PubMed ID: 29270818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important Considerations for the Treatment of Patients with Diabetes Mellitus and Heart Failure from a Diabetologist's Perspective: Lessons Learned from Cardiovascular Outcome Trials.
    Koliaki C; Katsilambros N
    Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31878281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure in patients with type 2 diabetes mellitus: assessment with echocardiography and effects of antihyperglycemic treatments.
    Iwakura K
    J Echocardiogr; 2019 Dec; 17(4):177-186. PubMed ID: 31617144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating the "MACE" in Cardiovascular Outcomes Trials and decoding the relevance of Atherosclerotic Cardiovascular Disease benefits versus Heart Failure benefits.
    Hupfeld C; Mudaliar S
    Diabetes Obes Metab; 2019 Aug; 21(8):1780-1789. PubMed ID: 30957945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?: Completed and Ongoing Mechanistic Trials.
    Lee MMY; Petrie MC; McMurray JJV; Sattar N
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):506-522. PubMed ID: 31996025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihyperglycemic Therapies to Treat Patients With Heart Failure and Diabetes Mellitus.
    Sharma A; Cooper LB; Fiuzat M; Mentz RJ; Ferreira JP; Butler J; Fitchett D; Moses AC; O'Connor C; Zannad F
    JACC Heart Fail; 2018 Oct; 6(10):813-822. PubMed ID: 30098964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart Failure in Type 2 Diabetes Mellitus.
    Kenny HC; Abel ED
    Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetes.
    Scheen AJ
    Diabetes Metab; 2019 Apr; 45(2):110-121. PubMed ID: 30477733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart Failure Considerations of Antihyperglycemic Medications for Type 2 Diabetes.
    Standl E; Schnell O; McGuire DK
    Circ Res; 2016 May; 118(11):1830-43. PubMed ID: 27230644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes: A Network Meta-Analysis.
    Kramer CK; Ye C; Campbell S; Retnakaran R
    JACC Heart Fail; 2018 Oct; 6(10):823-830. PubMed ID: 30196071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical potential relevance of metabolic properties of SGLT2 inhibitors in patients with heart failure.
    Galli M; D'Amario D; Sofia C; Vaccarella M; Crea F; Aspromonte N
    Expert Opin Drug Metab Toxicol; 2018 Dec; 14(12):1273-1285. PubMed ID: 30472914
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms by Which Glucagon-Like-Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Cardiovascular Risk in Adults With Type 2 Diabetes Mellitus.
    Sharma A; Verma S
    Can J Diabetes; 2020 Feb; 44(1):93-102. PubMed ID: 31882322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association.
    Ko SH; Hur KY; Rhee SY; Kim NH; Moon MK; Park SO; Lee BW; Kim HJ; Choi KM; Kim JH;
    Korean J Intern Med; 2017 Nov; 32(6):947-958. PubMed ID: 29056038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating Disease Mechanisms in Patients With Heart Failure and Diabetes Mellitus.
    Trang A; Aguilar D
    Curr Heart Fail Rep; 2017 Dec; 14(6):445-453. PubMed ID: 29094264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications.
    Heerspink HJ; Perkins BA; Fitchett DH; Husain M; Cherney DZ
    Circulation; 2016 Sep; 134(10):752-72. PubMed ID: 27470878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium Glucose Cotransporter-2 Inhibition in Heart Failure: Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials.
    Lytvyn Y; Bjornstad P; Udell JA; Lovshin JA; Cherney DZI
    Circulation; 2017 Oct; 136(17):1643-1658. PubMed ID: 29061576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.